First Thing, Daily Maverick's flagship newsletter

Join the 230 000 South Africans who read First Thing newsletter.

We'd like our readers to start paying for Daily Maverick

More specifically, we'd like those who can afford to pay to start paying. What it comes down to is whether or not you value Daily Maverick. Think of us in terms of your daily cappuccino from your favourite coffee shop. It costs around R35. That’s R1,050 per month on frothy milk. Don’t get us wrong, we’re almost exclusively fuelled by coffee. BUT maybe R200 of that R1,050 could go to the journalism that’s fighting for the country?

We don’t dictate how much we’d like our readers to contribute. After all, how much you value our work is subjective (and frankly, every amount helps). At R200, you get it back in Uber Eats and ride vouchers every month, but that’s just a suggestion. A little less than a week’s worth of cappuccinos.

We can't survive on hope and our own determination. Our country is going to be considerably worse off if we don’t have a strong, sustainable news media. If you’re rejigging your budgets, and it comes to choosing between frothy milk and Daily Maverick, we hope you might reconsider that cappuccino.

We need your help. And we’re not ashamed to ask for it.

Our mission is to Defend Truth. Join Maverick Insider.

Support Daily Maverick→
Payment options

Swazi prince accuses pharmaceuticals of exaggerating HI...

Africa

Africa, Politics, Sci-Tech

Swazi prince accuses pharmaceuticals of exaggerating HIV cases for profits

Prince Mangaliso, a top adviser to Swaziland's King Mswati III, drew the ire of Aids activists after saying that the HIV pandemic in Africa's last absolute monarchy was being exaggerated for the benefit of pharmaceutical companies. Activists called the remarks irresponsible. Mangaliso said public awareness campaigns against HIV were nothing more than scare tactics, and that male circumcision was just as effective as taking a bath after sexual intercourse. Now, where have we heard that one before? Read more: BBC News.

0

Gallery

Please peer review 3 community comments before your comment can be posted